MabCure, Inc.

27 articles about MabCure, Inc.

• MabCure, Inc. Announces Agreement with the City University of New York Center for Advanced Technology to Validate and Evaluate its Monoclonal Antibodies as Ovarian Cancer Diagnostic Reagents

  3/19/2012

• MabCure, Inc. Announces Completion of Its Ovarian Cancer Diagnostic Study in Thailand

  12/16/2011

• MabCure, Inc. Receives U$500,000.00 Licensing Fee as Well as 12.5% Ongoing Royalty for Its Prostate Cancer Diagnostic Technology

  11/23/2011

• MabCure, Inc. Study Results on a New Ovarian Cancer Diagnostic Blood Test Being Presented at the Annual Meeting of the Society of Gynecological Oncologists

  3/8/2011

• MabCure, Inc., Corporate Update

  3/1/2011

• MabCure, Inc. Secures $10 Million Funding Commitment from an Institutional Investor Managed by Roswell Capital Partners

  1/20/2011

• MabCure, Inc. Welcomes Dr. Charles T. Tackney as New Chief Scientific Officer

  12/6/2010

• MabCure, Inc. Completes 23.1 Million Australian Dollar Private Placement

  12/6/2010

• MabCure, Inc. Generates Tumor Specific Antibodies against Prostate Cancer Which Could Lead to a Blood/Urine Diagnostic Test for Prostate Cancer

  11/8/2010

• MabCure, Inc. Files Provisional Patent in the U.S. for Ovarian Cancer Antibodies

  8/3/2010

• MabCure, Inc. Announces Positive Results For New Ovarian Cancer Diagnostic Blood Test

  7/28/2010

• MabCure, Inc. Announces Positive Results for New Ovarian Cancer Diagnostic Blood Test

  7/27/2010

• MabCure, Inc. Completes a Private Placement in the Aggregate Amount of $1 million

  3/8/2010

• MabCure, Inc. Featured in GenomeWeb

  2/1/2010

• MabCure, Inc. Launches Clinical Trial to Diagnose Ovarian Cancer

  1/6/2010

• MabCure, Inc. Signs Research Agreement With AZ Sint Lucas Hospital, Brugge, Belgium, to Conduct Preclinical Research on its Monoclonal Antibodies (Mabs) Against Different Cancers

  11/4/2009

• MabCure, Inc. Produces Monoclonal Antibodies against Colorectal Cancer

  9/29/2009

• MabCure, Inc. Featured in GEN (Genetic Engineering & Biotechnology News)

  9/8/2009

• MabCure, Inc. Featured in Biotechnology Focus

  8/31/2009

• MabCure, Inc. Featured in BioWorld(R) Today

  8/25/2009